Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M31,489Revenue $M10,235Net Margin (%)16.6Z-Score3.2
Enterprise Value $M34,930EPS $3.6Operating Margin %20.8F-Score5
P/E(ttm))20.4Cash Flow Per Share $5.3Pre-tax Margin (%)19.8Higher ROA y-yN
Price/Book3.410-y EBITDA Growth Rate %6.6Quick Ratio1.6Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %6.1Current Ratio2.5Lower Leverage y-yN
Price/Cash Flow11.0y-y EBITDA Growth Rate %3.3ROA % (ttm)8.5Higher Current Ratio y-yY
Dividend Yield %1.8Insider Buy (3m)0ROE % (ttm)18.4Less Shares Outstanding y-yY
Payout Ratio %25.0Shares Outstanding M460ROI % (ttm)10.6Gross Margin Increase y-yN

Gurus Latest Trades with COV

Number of guru portfolios checked: 54.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
COVVanguard Health Care Fund 2013-12-31 Add0.22%$59.82 - $68.42
($65.08)
$ 69.867%Add 24.79%4,994,700
COVRay Dalio 2013-12-31 Buy 0.04%$59.82 - $68.42
($65.08)
$ 69.867%New holding, 80858 sh.80,858
COVJohn Keeley 2013-12-31 Reduce-0.06%$59.82 - $68.42
($65.08)
$ 69.867%Reduce -52.66%44,520
COVJoel Greenblatt 2013-12-31 Sold Out -0.03%$59.82 - $68.42
($65.08)
$ 69.867%Sold Out0
COVJoel Greenblatt 2013-09-30 Reduce-0.08%$57.12 - $63.8
($61.08)
$ 69.8614%Reduce -64.08%16,584
COVVanguard Health Care Fund 2013-06-30 Add0.37%$55.658 - $62.414
($59.39)
$ 69.8618%Add 66.94%4,002,600
COVJoel Greenblatt 2013-06-30 Buy 0.12%$55.658 - $62.414
($59.39)
$ 69.8618%New holding, 46170 sh.46,170
COVRonald Muhlenkamp 2013-06-30 Reduce-2.78%$55.658 - $62.414
($59.39)
$ 69.8618%Reduce -53.5%174,170
COVJean-Marie Eveillard 2013-06-30 Reduce-0.16%$55.658 - $62.414
($59.39)
$ 69.8618%Reduce -99.79%1,500
COVLeon Cooperman 2013-06-30 Sold Out -0.04%$55.658 - $62.414
($59.39)
$ 69.8618%Sold Out0
COVRay Dalio 2013-06-30 Sold Out -0.04%$55.658 - $62.414
($59.39)
$ 69.8618%Sold Out0
COVLeon Cooperman 2013-03-31 Buy 0.93%$57.74 - $67.84
($62.91)
$ 69.8611%New holding, 887300 sh.887,300
COVJean-Marie Eveillard 2013-03-31 Reduce-0.06%$57.74 - $67.84
($62.91)
$ 69.8611%Reduce -30.95%700,891
COVRay Dalio 2013-03-31 Reduce-0.01%$57.74 - $67.84
($62.91)
$ 69.8611%Reduce -22.49%60,996
COVRay Dalio 2012-12-31 Buy 0.05%$53.36 - $60.44
($57.11)
$ 69.8622%New holding, 78696 sh.78,696
COVJean-Marie Eveillard 2012-12-31 Reduce-0.06%$53.36 - $60.44
($57.11)
$ 69.8622%Reduce -21.14%1,014,988
COVJohn Paulson 2012-09-30 Sold Out -0.8%$50.6 - $59.77
($55.8)
$ 69.8625%Sold Out0
COVRay Dalio 2012-09-30 Sold Out -0.02%$50.6 - $59.77
($55.8)
$ 69.8625%Sold Out0
COVJean-Marie Eveillard 2012-06-30 Add0.08%$50.45 - $55.58
($53.41)
$ 69.8631%Add 44.58%1,297,817
COVDavid Dreman 2012-06-30 Sold Out -0.07%$50.45 - $55.58
($53.41)
$ 69.8631%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

COV is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
COV Yacktman Focused Fund 2014-03-31800,0000.170.62
COV Yacktman Fund 2014-03-31850,0000.180.56
COV Ray Dalio 2013-12-3180,8580.020.04New Buy
COV Vanguard Health Care Fund 2013-12-314,994,7001.091.1+24.79%
COV Ronald Muhlenkamp 2013-12-31181,6350.042.2+4.02%
COV Mario Gabelli 2013-12-31622,1520.140.23+1.52%
COV Jean-Marie Eveillard 2013-12-311,50000
COV Dodge & Cox 2013-12-31111,3170.020.01
COV Yacktman Fund 2013-12-31850,0000.180.53
COV Yacktman Focused Fund 2013-12-31800,0000.170.57
COV Donald Yacktman 2013-12-311,790,3750.390.5-0.31%
COV John Keeley 2013-12-3144,5200.010.05-52.66%
COV Joel Greenblatt 2013-12-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


COV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Dockendorff Charles JEVP & CFO 2014-03-28Sell90,730$72.5-3.64view
ALMEIDA JOSE EPresident and Chief Executive 2014-02-28Sell50,000$72-2.97view
Lannum Coleman N IIIVice President 2014-02-18Sell3,200$71.4-2.16view
BROWN RICHARD G JRVice President and Controller 2014-02-13Sell4,000$71-1.61view
Lannum Coleman N IIIVice President 2014-02-12Sell961$70.22-0.51view
King Brian DouglasVice President 2014-02-11Sell17,946$70-0.2view
Hanson Bryan CSenior Vice President 2014-02-11Sell32,480$69.97-0.16view
Wehrly Peter LSenior Vice President 2014-02-11Sell8,286$69.97-0.16view
Lannum Coleman N IIIVice President 2014-01-29Sell13,787$69.230.91view
BROWN RICHARD G JRVice President and Controller 2014-01-24Sell4,000$70-0.2view

Press Releases about COV :

    Quarterly/Annual Reports about COV:

    News about COV:

    Articles On GuruFocus.com
    4 Top Stocks in the Medical Device Sector Apr 11 2014 
    Weekly Insider Sells Highlight: CUK, CBI, COV, DWRE Mar 30 2014 
    Weekly CFO Sells Highlight: Chicago Bridge and Iron Company, Covidien PLC, Carnival PLC, Google Inc. Mar 30 2014 
    We Are Confident About Baxter's Plan to Create Two Separate Health Care Companies Mar 28 2014 
    Can Malllinckrodt Keep on Crushing Expectations? Mar 19 2014 
    Weekly 52-Week Highs Highlight: COV, EQT, XLNX, TEVA Mar 03 2014 
    Top Five Guru-Held UK and Ireland Stocks Dec 11 2013 
    Passion and Compassion - Paul Tudor Jones, Sells in Review Sep 24 2013 
    6 Large Cap Buy Rated Stocks With Healthy Cash Payment Boosts Sep 22 2013 
    The Alpha of Omega Advisors - Leon Cooperman's 6 Sells Aug 30 2013 

    More From Our Partners
    FDA Nod for Covidien's Kangaroo Feeding Tube - Analyst Blog Apr 16 2014 - ZACKS

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Hide